Infant Bacterial Therapeutics AB ( ($SE:IBT.B) ) has shared an update. Infant Bacterial Therapeutics AB has partnered with ...

EU Commissioner for Enlargement Marta Kos looks at a production hall damaged after a recent Russian missile attack at DTEK's ...

In a significant leap forward, Birla Opus Paints, part of the Grasim Industries family, has transformed its operations ...

Monster Beverage gains global market share with Ultra line, strong margins, emerging market penetration, and supply chain ...

Oil majors operating in Brazil have closed ranks to oppose a proposed merger between energy contractors Subsea7 and Saipem, ...

IBP-9414 will be the first live biotherapeutic product globally, according to officials at Infant Bacterial Therapeutics in Stockholm.

Following today's meeting with the FDA concerning IBT's live biotherapeutic product, IBT has decided to pursue an accelerated approval pathway for IBP-9414. The FDA's Accelerated Approval Program allo ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Building products installation services company Installed Building Products (NYSE:IBP) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 2.3% year on year to $778.2 million. Its ...

The Department of Tourism (DOT) and the Integrated Bar of the Philippines (IBP) are working together to provide legal aid for DOT-accredited tourism enterprises and introduce a privilege card for ...

Installed Building Products, Inc. IBP has accelerated its growth trajectory and expanded its geographic footprint through the strategic acquisitions of Echols Glass & Mirror, Inc. (“Echols”) and ...

COLUMBUS, Ohio - Installed Building Products, Inc. (NYSE:IBP), a national installer of insulation and complementary building products, announced Monday the acquisition of Echols Glass & Mirror, Inc.